KLK10 could thus be an interesting target for NF-PitNETs, but currently more studies on its pathophysiologic and mechanistic implications should be performed, either silencing or overexpressing its gene in order to clearly define its implications in tumor growth as well as its potential therapeutic use. The gene discussed is KLK10; the disease is neoplasm.